Abstract
Candida peritonitis is associated with high mortality and multiple organ failure. With an evolving epidemiology of candidaemia indicating an increasing prevalence of rare Candida species worldwide, consideration of multidrug-resistant fungal pathogens as a cause of abdominal sepsis is paramount. We report three cases of Candida krusei as a cause of secondary and tertiary peritonitis. These cases highlight that the early use of an echinocandin class antifungal in patients not responding to standard regimens warrants consideration.
| Original language | English |
|---|---|
| Pages (from-to) | 3428-3431 |
| Number of pages | 4 |
| Journal | International Surgery Journal |
| Volume | 7 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2020 |
Open Access - Access Right Statement
© the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Fingerprint
Dive into the research topics of 'First reported case series of Candida krusei peritonitis secondary to a perforated viscus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver